Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Total Debt (2016 - 2025)

Conmed (CNMD) has disclosed Total Debt for 16 consecutive years, with $834.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt fell 7.82% year-over-year to $834.9 million, compared with a TTM value of $834.9 million through Dec 2025, down 7.82%, and an annual FY2025 reading of $834.9 million, down 7.82% over the prior year.
  • Total Debt was $834.9 million for Q4 2025 at Conmed, down from $853.8 million in the prior quarter.
  • Across five years, Total Debt topped out at $1.1 billion in Q1 2023 and bottomed at $684.7 million in Q4 2021.
  • Average Total Debt over 5 years is $901.2 million, with a median of $923.3 million recorded in 2024.
  • The sharpest move saw Total Debt skyrocketed 54.07% in 2022, then decreased 9.96% in 2025.
  • Year by year, Total Debt stood at $684.7 million in 2021, then surged by 54.07% to $1.1 billion in 2022, then dropped by 7.68% to $973.8 million in 2023, then dropped by 6.99% to $905.8 million in 2024, then decreased by 7.82% to $834.9 million in 2025.
  • Business Quant data shows Total Debt for CNMD at $834.9 million in Q4 2025, $853.8 million in Q3 2025, and $881.8 million in Q2 2025.